Latest News from: American Thoracic Society (ATS)

Filters close
Newswise: Lack of Knowledge Is One Barrier to Prone Positioning in Severe ARDS Caused by COVID-19
7-Oct-2020 8:55 AM EDT
Lack of Knowledge Is One Barrier to Prone Positioning in Severe ARDS Caused by COVID-19
American Thoracic Society (ATS)

A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.

Newswise: Face Masks Unlikely to Cause Over-exposure to Carbon Dioxide, Even in Patients with Lung Disease
30-Sep-2020 1:50 PM EDT
Face Masks Unlikely to Cause Over-exposure to Carbon Dioxide, Even in Patients with Lung Disease
American Thoracic Society (ATS)

New research findings contradict statements linking wearing face masks to carbon dioxide poisoning by trapping CO2. During the COVID-19 pandemic the wearing of face masks has become a highly political issue with some individuals falsely claiming that wearing face masks may be putting people’s health at risk. The study published in the Annals of the American Thoracic Society shows otherwise.

Newswise: ATS Research Program, 4DMedical Announce Grant Opportunities for Research in Asthma, COPD and IPF
Released: 1-Oct-2020 8:05 AM EDT
ATS Research Program, 4DMedical Announce Grant Opportunities for Research in Asthma, COPD and IPF
American Thoracic Society (ATS)

Today, the ATS Research Program announced three research grant opportunities with support from 4DMedical, a global medical technology company with a focus on lung health. With a total grant support of $150,000, each of the three $50,000 grants will fund research in asthma, chronic obstructive pulmonary disorder or COPD, and idiopathic pulmonary fibrosis or IPF.

Released: 28-Sep-2020 4:20 PM EDT
Executive Order Mandating How to Address Race and Diversity: ATS Responds
American Thoracic Society (ATS)

Today, the leadership of the American Thoracic Society issued the following statement in response to the recent executive order by the Trump Administration: On Sept. 22 the President signed an executive order titled “Combating Race and Sex Stereotyping”, which seeks to censor federal agency education efforts to address racial inequality in America.

Newswise: World Lung Day 2020: Respiratory Groups Call for Research to Prevent, Detect and Treat Respiratory Infections
Released: 25-Sep-2020 9:45 AM EDT
World Lung Day 2020: Respiratory Groups Call for Research to Prevent, Detect and Treat Respiratory Infections
American Thoracic Society (ATS)

Today, on World Lung Day (WLD), the American Thoracic Society is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations to advocate for respiratory health globally and call for more research to prevent, detect and treat respiratory infections.

Newswise: Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
22-Sep-2020 4:00 PM EDT
Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
American Thoracic Society (ATS)

A new Viewpoint piece published online in the Annals of the American Thoracic Society examines the ways in which COVID-19 disproportionately impacts historically disadvantaged communities of color in the United States, and how baseline inequalities in our health system are amplified by the pandemic. The authors also discuss potential solutions.

Newswise: ATS Research Program/ Mallinckrodt Pharmaceuticals Grant Opportunity in Sarcoidosis
Released: 17-Sep-2020 8:00 AM EDT
ATS Research Program/ Mallinckrodt Pharmaceuticals Grant Opportunity in Sarcoidosis
American Thoracic Society (ATS)

The ATS Research Program is pleased to announce a new one-year grant supporting sarcoidosis research. The award by Mallinckrodt Pharmaceuticals provides $50,000 in funding.

Newswise: CDC Data Shows E-cigarette Makers Continues to Prey on Youth – and FDA Policy Lets Them
Released: 9-Sep-2020 4:55 PM EDT
CDC Data Shows E-cigarette Makers Continues to Prey on Youth – and FDA Policy Lets Them
American Thoracic Society (ATS)

Today, the CDC released data from the National Youth Tobacco Survey showing that in 2020, 20 percent of high school students and nearly 5 percent of middle school students used e-cigarettes. Most concerning, the data shows that among youth e-cigarette users, 38.9 percent of high school students and 20 percent of middle school students reported using e-cigarettes on 20 or more of the past 30 days; 22.5 percent of high school users and 9.4 percent of middle school users reported daily use.

Newswise: American Thoracic Society/CSL Behring Research Award in ARDS Announced
Released: 9-Sep-2020 8:00 AM EDT
American Thoracic Society/CSL Behring Research Award in ARDS Announced
American Thoracic Society (ATS)

The ATS Research Program is pleased to announce the new ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome or ARDS. The award will provide $50,000 in funding for one year.

Newswise: Asthma May Not Be a Significant Risk Factor for Severe COVID-19 or COVID-Related Intubation
Released: 31-Aug-2020 8:00 AM EDT
Asthma May Not Be a Significant Risk Factor for Severe COVID-19 or COVID-Related Intubation
American Thoracic Society (ATS)

A new research letter published online in the Annals of the American Thoracic Society examines whether asthma is a significant risk factor for developing COVID-19 that is severe enough to warrant hospitalization and intubation. According to the Centers for Disease Control and Prevention, individuals with asthma are at higher risk for hospitalization and other severe effects from COVID-19, similar to the elevated risk from such health conditions as obesity, hypertension and diabetes.

Newswise: ATS Statement on Latest COVID-19 Policy Actions: Convalescent Plasma and Testing of Asymptomatic Patients
Released: 28-Aug-2020 10:35 AM EDT
ATS Statement on Latest COVID-19 Policy Actions: Convalescent Plasma and Testing of Asymptomatic Patients
American Thoracic Society (ATS)

The American Thoracic Society is alarmed by two federal agency policy actions that may significantly impact our nation’s COVID-19 response. This week, the FDA issued an emergency use authorization (EUA) for the use of convalescent plasma to treat COVID-19 disease. This action was taken despite a lack of adequate evidence demonstrating a clear benefit for most patients. As pulmonary and critical care clinicians and researchers who treat individuals with COVID-19, we are concerned that an EUA for convalescent plasma has the potential to put patients at risk.

Released: 27-Aug-2020 8:35 AM EDT
Bounce Back Better: Sustainable Strategies for a Healthy Recovery from the Pandemic
American Thoracic Society (ATS)

The American Thoracic Society (ATS), European Respiratory Society (ERS) and International Society for Environmental Epidemiology (ISEE) are dedicated to improving health around the globe, with ATS and ERS achieving this goal by advancing research, patient care and public health in pulmonary diseases, while ISEE advances research on environment and health.

Newswise: New Clinical Practice Guidelines on Non-Invasive Ventilation in Chronic Stable 
Hypercapnic COPD;
Released: 17-Aug-2020 8:00 AM EDT
New Clinical Practice Guidelines on Non-Invasive Ventilation in Chronic Stable Hypercapnic COPD;
American Thoracic Society (ATS)

A subcommittee of the American Thoracic Society Assembly in Sleep and Respiratory Neurobiology has released new clinical practice guidelines to help advise clinicians on the optimal management of patients with chronic obstructive pulmonary disease (COPD) and chronic hypercapnia. Hypercapnia is the buildup of carbon dioxide in the bloodstream.

Newswise: Image%201
7-Aug-2020 9:00 AM EDT
Blood-based lung nodule testing presentation at ATS 2020 Virtual
American Thoracic Society (ATS)

Nodify Lung™ testing helps reclassify risk of malignancy of nodules by identifying patients with a higher or lower risk than indicated by traditional risk assessment

Newswise:Video Embedded i-m-a-public-health-physician-and-scientist-and-i-m-blocking-the-path-of-an-oil-pipeline-to-protect-health
VIDEO
Released: 7-Aug-2020 3:50 PM EDT
I'm a public health physician and scientist and I'm blocking the path of an oil pipeline to protect health
American Thoracic Society (ATS)

As a doctor, I didn’t expect to find myself living in a tree at the age of 63, but here I am: 82 feet (25 meters) off the ground in a lovely grove of old cotton wood trees trying to stop construction on an oil pipeline.

Newswise: Challenges in Diagnosing Hypersensitivity Pneumonitis Addressed in Latest Guidelines for Clinicians
Released: 3-Aug-2020 8:00 AM EDT
Challenges in Diagnosing Hypersensitivity Pneumonitis Addressed in Latest Guidelines for Clinicians
American Thoracic Society (ATS)

Aug. 3, 2020─ More than 30 years after the last guidance on the clinical evaluation of hypersensitivity pneumonitis (HP), the American Thoracic Society – in collaboration with the Asociación Latinoamericana de Tórax or ALAT and the Japanese Respiratory Society– has developed new guidelines for clinicians. The guidelines are available online ahead of print in the American Journal of Respiratory and Critical Care Medicine.

Released: 28-Jul-2020 2:10 PM EDT
Press Register Now; ATS 2020 Virtual Starts Aug. 5
American Thoracic Society (ATS)

Join us on Aug. 5-10 2020 for ATS 2020 Virtual, when the American Thoracic Society will host a mix of live and pre-recorded sessions in pulmonary, critical care, and sleep medicine. Press are invited to attend (see press guidelines) and may register now. Same day registration will be available during the meeting.

Newswise: ATS Publishes New Guidance on Safely Restoring Elective Pulmonary and Sleep Services
Released: 16-Jul-2020 8:00 AM EDT
ATS Publishes New Guidance on Safely Restoring Elective Pulmonary and Sleep Services
American Thoracic Society (ATS)

An American Thoracic Society-led international task force has released a guidance document to help guide clinicians on restoring elective in-person pulmonary and sleep services as COVID-19 incidence decreases in their communities. The new guidance, published online in the Annals of the American Thoracic Society, is titled “Restoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens.”

Newswise: Experts Strongly Recommend Varenicline Over the Patch for Adult Smokers Hoping to Quit
Released: 15-Jul-2020 8:00 AM EDT
Experts Strongly Recommend Varenicline Over the Patch for Adult Smokers Hoping to Quit
American Thoracic Society (ATS)

Smoking cessation initiatives notwithstanding, along with provocative public health campaigns and clinical guidance, quitting tobacco has remained elusive for many smokers. The American Thoracic Society’s new clinical practice guideline on treatment for tobacco dependence in adults addresses how clinicians may deal with patients’ reluctance to quit, one of a number of issues not previously assessed in the older guidelines.

Newswise: Black Individuals at Higher Risk for Contracting COVID-19, According to New Research
Released: 9-Jul-2020 8:00 AM EDT
Black Individuals at Higher Risk for Contracting COVID-19, According to New Research
American Thoracic Society (ATS)

Results of an analysis published in the Annals of the American Thoracic Society found that Black individuals were twice as likely as White individuals to test positive for COVID-19. The average age of all participants in the study was 46. However, those infected were on average 52 years old, compared to those who tested negative, who were 45 years old on average.

Released: 8-Jul-2020 7:00 AM EDT
Move to Withdraw U.S. from WHO During Global COVID-19 Pandemic Very Concerning
American Thoracic Society (ATS)

The American Thoracic Society (ATS) is deeply concerned by the Trump Administration’s action today to withdraw the United States from the World Health Organization (WHO).

Released: 6-Jul-2020 10:20 AM EDT
The Forum of International Respiratory Societies: We Must Continue to Be Vigilant to Control the Spread of COVID-19
American Thoracic Society (ATS)

COVID-19 cases continue to rise globally. Some countries are still dealing with large epidemics, while others are at various stages of reopening society. Many countries are fearful of a second wave of infection, as a consequence of restrictions being eased.

Newswise: Understanding Molecular Mechanisms of Air Pollution’s Impact on Interstitial Lung Disease is Critical to Minimizing its Effects
Released: 1-Jul-2020 8:00 AM EDT
Understanding Molecular Mechanisms of Air Pollution’s Impact on Interstitial Lung Disease is Critical to Minimizing its Effects
American Thoracic Society (ATS)

More research must be done to investigate the role of air pollution on the epigenome in patients with interstitial lung diseases (ILDs), in order to develop strategies that minimize the effects of these pollutants, according to a new article published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Newswise: “For My Lung Health” Campaign Promotes Lung Health Education in Underserved Black and Latino Communities
Released: 29-Jun-2020 8:00 AM EDT
“For My Lung Health” Campaign Promotes Lung Health Education in Underserved Black and Latino Communities
American Thoracic Society (ATS)

This month the American Thoracic Society (ATS) and the American College of Chest Physicians (CHEST) launched For My Lung Health, a patient-education website and media campaign. Using public service announcements and an education-based website, For My Lung Health focuses on empowering people from underserved communities who live with chronic lung disease.

Newswise: Countries with Early Adoption of Face Masks Showed Modest COVID-19 Infection Rates
Released: 24-Jun-2020 8:00 AM EDT
Countries with Early Adoption of Face Masks Showed Modest COVID-19 Infection Rates
American Thoracic Society (ATS)

Regions with an early interest in face masks had milder COVID-19 epidemics, according to a new letter-to-the-editor published in the American Journal of Respiratory and Critical Care Medicine.

Released: 22-Jun-2020 3:10 PM EDT
Cover Clinical Trials Session, June 24, Before ATS 2020 Virtual Kick-Off
American Thoracic Society (ATS)

ATS 2020 Virtual is taking place on Aug. 5-10, but you can register for “Breaking News: Clinical Trial Results in Pulmonary Medicine,” a preview session taking place on June 24 at 2-3:45 pm ET. Review program details here. Please note that all content for the Clinical Trial Results session is embargoed until 2 p.m. ET June 24.

Newswise: New Article Clarifies Details of COVID-19 Respiratory Transmission
Released: 22-Jun-2020 8:00 AM EDT
New Article Clarifies Details of COVID-19 Respiratory Transmission
American Thoracic Society (ATS)

In a new article, scientists provide an exhaustive, evidence-based review of how COVID-19 droplets from infected patients spread through the air and describe how health care professionals can protect themselves. This Pulmonary Perspective is published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Newswise: Tear Gas Use During COVID-19 Pandemic Irresponsible; Moratorium Needed, Says American Thoracic Society
Released: 11-Jun-2020 4:50 PM EDT
Tear Gas Use During COVID-19 Pandemic Irresponsible; Moratorium Needed, Says American Thoracic Society
American Thoracic Society (ATS)

The American Thoracic Society calls for a moratorium on the use of tear gas and other chemical agents deployed by law enforcement against protestors participating in demonstrations, including current campaigns sparked by the death of George Floyd.

Newswise: Nation Must Prepare for COVID-19 Related Drug Shortages
Released: 11-Jun-2020 8:00 AM EDT
Nation Must Prepare for COVID-19 Related Drug Shortages
American Thoracic Society (ATS)

A new paper published online in the Annals of the American Thoracic Society examines the nation’s current shortage of vitally needed medications, and how this dangerous situation is being made worse by the COVID-19 pandemic. The authors provide recommendations on how clinicians and institutions might address potential scarcities of essential medications during the current public health crisis.

Newswise: EPA Proposal to Change How It Evaluates Environmental Policy Ignores Science
Released: 5-Jun-2020 3:55 PM EDT
EPA Proposal to Change How It Evaluates Environmental Policy Ignores Science
American Thoracic Society (ATS)

The American Thoracic Society is extremely concerned with today’s announcement about changes in how the EPA evaluates the costs and benefits of environmental policy. While the details of economic analysis of environmental regulations are complex, the guiding principle is remarkably simple: compare all the costs and benefits of agency actions. The proposed changes in how costs and benefits are evaluated will sufficiently degrade the credibility of economic analysis conducted at the EPA to the point that it is no longer able to function as an objective policy analysis tool.

Newswise: Reducing Severe Breathlessness and Psychological Trauma in COVID-19 ARDS Survivors
2-Jun-2020 8:00 AM EDT
Reducing Severe Breathlessness and Psychological Trauma in COVID-19 ARDS Survivors
American Thoracic Society (ATS)

A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome (ARDS) with mechanical ventilation.

Newswise: ATS Announces $500,000 COVID-19 Crisis Fund Support from AstraZeneca
Released: 3-Jun-2020 8:15 AM EDT
ATS Announces $500,000 COVID-19 Crisis Fund Support from AstraZeneca
American Thoracic Society (ATS)

June 3, 2020 –Today, the American Thoracic Society (ATS) announced a $500,000 donation from AstraZeneca to the ATS COVID-19 Crisis Fund, launched to support the Society’s all-encompassing efforts to fight COVID-19.

Released: 1-Jun-2020 4:05 PM EDT
ATS Responds to the Death of George Floyd and Subsequent Events
American Thoracic Society (ATS)

Today, the American Thoracic Society issued the following statement regarding the death of George Floyd: The recent tragic death of Mr. George Floyd in Minneapolis and subsequent protests throughout the United States and in cities around the world call on us to again examine the role of the American Thoracic Society. As an international professional organization whose members are on the front lines of providing care to all citizens, our members are now experiencing first-hand some of the effects of these events.

Newswise: Analysis Does Not Find Two Distinct Subphenotypes of COVID-19 Related ARDS
Released: 27-May-2020 8:00 AM EDT
Analysis Does Not Find Two Distinct Subphenotypes of COVID-19 Related ARDS
American Thoracic Society (ATS)

In a new paper published online in the Annals of the American Thoracic Society, researchers have been unable to produce two theorized subphenotypes of COVID-19 related acute respiratory distress syndrome (ARDS). Scientists previously proposed that two phenotypes exist that differentiate patients with more severe COVID-19 and indicate that they should be treated differently. A phenotype is a set of characteristics used to classify a patient, which may influence disease management.

Newswise: Modified Clinical Trial Protocol Created in Response to Urgency of COVID-19 Pandemic
Released: 19-May-2020 8:00 AM EDT
Modified Clinical Trial Protocol Created in Response to Urgency of COVID-19 Pandemic
American Thoracic Society (ATS)

A new paper published online in the Annals of the American Thoracic Society describes a nimble, pragmatic and rigorous multicenter clinical trial design to meet urgent community needs in the face of the COVID-19 pandemic.

Newswise: Innovative Communication System Protects Health Professionals Treating
Infectious Disease Patients
Released: 12-May-2020 8:00 AM EDT
Innovative Communication System Protects Health Professionals Treating Infectious Disease Patients
American Thoracic Society (ATS)

Physician-scientists have developed a communication management system built on a telemedicine platform that can help minimize the exposure of health care professionals to highly infectious diseases while still providing personalized patient care, according to a new report published online in the Annals of the American Thoracic Society.

Newswise: ATS COVID-19 Crisis Fund Receives $100,000 Donation from Gilead Sciences, Inc.
Released: 11-May-2020 8:00 AM EDT
ATS COVID-19 Crisis Fund Receives $100,000 Donation from Gilead Sciences, Inc.
American Thoracic Society (ATS)

May 11, 2020 -- Today, the American Thoracic Society announced a $100,000 donation from Gilead Sciences, Inc. to support the ATS COVID-19 Crisis Fund. This donation from Gilead is the latest in a highly appreciated increase in funding support from industry.

Newswise: ATS Announces GSK Grants to Support COVID-19 Crisis Fund’s Research and Outreach Efforts
Released: 5-May-2020 10:00 AM EDT
ATS Announces GSK Grants to Support COVID-19 Crisis Fund’s Research and Outreach Efforts
American Thoracic Society (ATS)

Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. The first grant will fund two new $50,000 grants in the ATS Research Program in COVID-19. The second grant for $280,000 will support the Society’s patient education and outreach efforts related to COVID-19.

Newswise: Clinicians Warn of the Dangers of Equating COVID-19 with High Altitude Pulmonary Edema
Released: 30-Apr-2020 8:00 AM EDT
Clinicians Warn of the Dangers of Equating COVID-19 with High Altitude Pulmonary Edema
American Thoracic Society (ATS)

Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE.

Newswise: In Preparing for COVID-19 Cases, Plan Early, Communicate Often Says Critical Care Specialists
Released: 27-Apr-2020 4:25 PM EDT
In Preparing for COVID-19 Cases, Plan Early, Communicate Often Says Critical Care Specialists
American Thoracic Society (ATS)

Hospitals facing a growing population of COVID-19 cases need a coordinated approach with a multidisciplinary team to increase efficiency, conserve PPE and protect staff. In “Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective,” – published online in the American Journal of Respiratory and Critical Care Medicine – experts from Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center share their roadmap for meeting challenges posed by the pandemic, including an influx of critically ill patients.

Newswise: Clinicians Treating COVID-19 Say Don’t Rush to Try Novel Therapies Without Proof of Benefit
Released: 27-Apr-2020 8:00 AM EDT
Clinicians Treating COVID-19 Say Don’t Rush to Try Novel Therapies Without Proof of Benefit
American Thoracic Society (ATS)

Intensivists caution against the use of premature novel therapies in lieu of traditional critical care principles in patients with COVID-19 in a recent correspondence letter in the American Journal of Respiratory Cell and Molecular Biology.

Newswise: Establish Contingency Plans to Meet COVID-19 Surge in Urban Areas, Say Experts at Leading Academic Medical Center
Released: 21-Apr-2020 1:00 PM EDT
Establish Contingency Plans to Meet COVID-19 Surge in Urban Areas, Say Experts at Leading Academic Medical Center
American Thoracic Society (ATS)

In “Mobilization and Preparation of a Large Urban Academic Center During the COVID-19 Pandemic,”– published online in the Annals of the American Thoracic Society – experts from Philadelphia’s Temple University Hospital share their contingency plans for meeting an increased demand for hospitalization, as well as their protocols and training plans to minimize health care staff exposure to COVID-19 and ensure proper active and reserve staffing.

Newswise: First Official ATS Practice Guidelines for Sarcoidosis Cover Diagnosis and Detection
Released: 20-Apr-2020 3:35 PM EDT
First Official ATS Practice Guidelines for Sarcoidosis Cover Diagnosis and Detection
American Thoracic Society (ATS)

New guidance is available for physicians who must go through a number of steps to provide a probable diagnosis of sarcoidosis – an inflammatory disease that affects the lungs, lymph glands, and other organs.

Released: 17-Apr-2020 4:20 PM EDT
EPA’S Attempt to Roll Back Regulations on Mercury and Toxic Air Emissions Ignores Science, Common Sense
American Thoracic Society (ATS)

Against the recommendation of the environmental, public health and even the electric power industry, this week the Environmental Protection Agency issued final rules to roll back regulations on mercury and toxic air emissions from our nation’s coal and oil-fired power plants. To justify taking such action, says the American Thoracic Society, the EPA ignored years of precedent – used by both Republican and Democratic Administrations – determining how the agency conducts cost benefit analysis of environmental regulations.

Newswise: ECMO Physicians Offer Guidance in the Context of Resource-scarce COVID-19 Treatment
Released: 15-Apr-2020 8:00 AM EDT
ECMO Physicians Offer Guidance in the Context of Resource-scarce COVID-19 Treatment
American Thoracic Society (ATS)

Rapidly escalating numbers of COVID-19 patients suffering from respiratory failure threaten to overwhelm hospital capacity and force healthcare providers into making challenging decisions about the care they provide. Of particular interest is the role of ECMO – extracorporeal membrane oxygenation, a form of life support for patients with advanced lung disease – to support critically ill patients in the current pandemic.

Released: 14-Apr-2020 8:00 AM EDT
LABA/LAMA Combination Therapy More Effective for COPD Patients with Exercise Intolerance
American Thoracic Society (ATS)

Clinicians grappling with the pharmacologic management of COPD in patients complaining of exercise intolerance or dyspnea now have new guidance. The American Thoracic Society has published an official clinical practice guideline in which a panel of experts strongly recommended LABA/LAMA combination therapy over LABA or LAMA alone. The complete guideline detailing all the recommendations was posted online ahead of print in the American Journal of Respiratory and Critical Care Medicine.

Newswise: Study Demonstrates the Need for Immediate ICU Care for Severe COVID-19 Pneumonia, Describes Patient Characteristics
Released: 7-Apr-2020 1:45 PM EDT
Study Demonstrates the Need for Immediate ICU Care for Severe COVID-19 Pneumonia, Describes Patient Characteristics
American Thoracic Society (ATS)

Researchers have identified the most common clinical characteristics of 109 patients with COVID-19 related pneumonia who died in Wuhan, China in the early stages of the coronavirus pandemic, according to a new study published online in the Annals of the American Thoracic Society.


Showing results

150 of 1123

close
1.44475